New diabetes pill shows promise in Final-Stage testing
NCT ID NCT00998881
Summary
This study tested whether a new medication called Teneligliptin (MP-513) could safely help control blood sugar in people with type 2 diabetes. It involved 203 Japanese adults who were managing their diabetes with diet and exercise alone. For 12 weeks, participants received either the new drug or a placebo pill to compare their blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Sapporo, Hokkaido, Japan
Conditions
Explore the condition pages connected to this study.